Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
Bufei Yishen formula (BYF) is a Traditional Chinese Medicine (TCM) reported to ameliorate chronic obstructive pulmonary disease (COPD) by regulating the balance between T helper (Th) 17 and regulatory T (Treg) cells. However, its mechanism remains unknown. Therefore, this study aimed to explore the...
Saved in:
Main Authors: | Peng Zhao (Author), Xuefang Liu (Author), Haoran Dong (Author), Yange Tian (Author), Suxiang Feng (Author), Di Zhao (Author), Zhouxin Ren (Author), Lanxi Zhang (Author), Jiansheng Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway
by: Lidan Jia, et al.
Published: (2024) -
Bufei Jianpi Formula Improves Mitochondrial Function and Suppresses Mitophagy in Skeletal Muscle via the Adenosine Monophosphate-Activated Protein Kinase Pathway in Chronic Obstructive Pulmonary Disease
by: Jing Mao, et al.
Published: (2020) -
The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD
by: Jiansheng Li, et al.
Published: (2021) -
A Chinese Herbal Formula Ameliorates Pulmonary Fibrosis by Inhibiting Oxidative Stress via Upregulating Nrf2
by: Yunping Bai, et al.
Published: (2018) -
Hesperidin inhibits the epithelial to mesenchymal transition induced by transforming growth factor-β1 in A549 cells through Smad signaling in the cytoplasm
by: Zhouxin Ren, et al.
Published: (2019)